Patient-level detection of grade group ≥2 prostate cancer using quantitative diffusion MRI

Published on May 26, 2021in medRxiv
· DOI :10.1101/2021.05.24.21256461
Zhong Ay (UCSD: University of California, San Diego), Leonardino A. Digma2
Estimated H-index: 2
(UCSD: University of California, San Diego)
+ 13 AuthorsTyler M. Seibert18
Estimated H-index: 18
Sources
Abstract
PurposeMultiparametric MRI (mpMRI) improves detection of clinically significant prostate cancer (csPCa), but the qualitative PI-RADS system and quantitative apparent diffusion coefficient (ADC) yield inconsistent results. An advanced Restrictrion Spectrum Imaging (RSI) model may yield a better quantitative marker for csPCa, the RSI restriction score (RSIrs). We evaluated RSIrs for patient-level detection of csPCa. Materials and MethodsRetrospective analysis of men who underwent mpMRI with RSI and prostate biopsy for suspected prostate cancer from 2017-2019. Maximum RSIrs within the prostate was assessed by area under the receiver operating characteristic curve (AUC) for discriminating csPCa (grade group [≥]2) from benign or grade group 1 biopsies. Performance of RSIrs was compared to minimum ADC and PI-RADS v2-2.1via bootstrap confidence intervals and bootstrap difference (two-tailed =0.05). We also tested whether the combination of PI-RADS and RSIrs (PI-RADS+RSIrs) was superior to PI-RADS, alone. Results151 patients met criteria for inclusion. AUC values for ADC, RSIrs, and PI-RADS were 0.50 [95% confidence interval: 0.41, 0.60], 0.76 [0.68, 0.84], and 0.78 [0.71, 0.85], respectively. RSIrs (p=0.0002) and PI-RADS (p<0.0001) were superior to ADC for patient-level detection of csPCa. The performance of RSIrs was comparable to that of PI-RADS (p=0.6). AUC for PI-RADS+RSIrs was 0.84 [0.77, 0.90], superior to PI-RADS or RSIrs, alone (p=0.008, p=0.009). ConclusionsRSIrs was superior to conventional ADC and comparable to (routine, clinical) PI-RADS for patient-level detection of csPCa. The combination of PI-RADS and RSIrs was superior to either alone. RSIrs is a promising quantitative marker worthy of prospective study in the setting of csPCa detection. DisclosuresMEH reports honoraria from Multimodal Imaging Services Corporation and research funding from General Electric Healthcare. AMD is a Founder of and holds equity in CorTechs Labs, Inc, and serves on its Scientific Advisory Board. He is a member of the Scientific Advisory Board of Human Longevity, Inc. and receives funding through research agreements with General Electric Healthcare. The terms of these arrangements have been reviewed and approved by the University of California San Diego in accordance with its conflict-of-interest policies. TMS reports honoraria from Multimodal Imaging Services Corporation, Varian Medical Systems, and WebMD; he has an equity interest in CorTechs Labs, Inc. and also serves on its Scientific Advisory Board. These companies might potentially benefit from the research results. The terms of this arrangement have been reviewed and approved by the University of California San Diego in accordance with its conflict-of-interest policies.
📖 Papers frequently viewed together
20162.74PLOS ONE
10 Authors (Susanne Tewes, ..., Katja Hueper)
35 Citations
4 Citations
2 Citations
References28
Newest
2 CitationsSource
#1Laurence Klotz (Sunnybrook Health Sciences Centre)H-Index: 85
#2Joseph L. Chin (London Health Sciences Centre)H-Index: 64
Last. Masoom A. Haider (TGH: Toronto General Hospital)H-Index: 1
view all 20 authors...
Importance Magnetic resonance imaging (MRI) with targeted biopsy is an appealing alternative to systematic 12-core transrectal ultrasonography (TRUS) biopsy for prostate cancer diagnosis, but has yet to be widely adopted. Objective To determine whether MRI with only targeted biopsy was noninferior to systematic TRUS biopsies in the detection of International Society of Urological Pathology grade group (GG) 2 or greater prostate cancer. Design, Setting, and Participants This multicenter, prospect...
16 CitationsSource
#1Christopher C. Conlin (UCSD: University of California, San Diego)H-Index: 3
#2Christine H. Feng (UCSD: University of California, San Diego)H-Index: 5
Last. Anders M. Dale (UCSD: University of California, San Diego)H-Index: 166
view all 10 authors...
BACKGROUND Multicompartmental modeling outperforms conventional diffusion-weighted imaging (DWI) in the assessment of prostate cancer. Optimized multicompartmental models could further improve the detection and characterization of prostate cancer. PURPOSE To optimize multicompartmental signal models and apply them to study diffusion in normal and cancerous prostate tissue in vivo. STUDY TYPE Retrospective. SUBJECTS Forty-six patients who underwent MRI examination for suspected prostate cancer; 2...
2 CitationsSource
#1Jonathan Sackett (LLU: Loma Linda University)H-Index: 4
#2Joanna H. ShihH-Index: 27
Last. Baris TurkbeyH-Index: 76
view all 18 authors...
Rationale and Objective The Prostate Imaging Reporting and Data System version 2 (PI-RADSv2) published a set of minimum technical standards (MTS) to improve image quality and reduce variability in multiparametric prostate MRI. The effect of PIRADSv2 MTS on image quality has not been validated. We aimed to determine whether adherence to PI-RADSv2 MTS improves study adequacy and perceived quality. Materials and Methods Sixty-two prostate MRI examinations including T2 weighted (T2W) and diffusion w...
12 CitationsSource
#1Alexey Surov (Leipzig University)H-Index: 25
#2Hans Jonas Meyer (Leipzig University)H-Index: 18
Last. Andreas Wienke (MLU: Martin Luther University of Halle-Wittenberg)H-Index: 30
view all 3 authors...
Abstract Background Reported data regarding the associations between apparent diffusion coefficient (ADC) of diffusion-weighted imaging (DWI) and Gleason score in prostate cancer (PC) are inconsistent. Objective The aim of the present systematic review was to analyze relationships between ADC and Gleason score in PC. Design, setting, and participants MEDLINE library, SCOPUS, and EMBASE databases were screened for relationships between ADC and Gleason score in PC up to April 2018. Overall, 39 stu...
18 CitationsSource
#1Christine H. Feng (UCSD: University of California, San Diego)H-Index: 5
#2Christopher C. Conlin (UCSD: University of California, San Diego)H-Index: 3
Last. Tyler M. Seibert (UCSD: University of California, San Diego)H-Index: 18
view all 11 authors...
Purpose: Diffusion MRI is integral to detection of prostate cancer (PCa), but conventional ADC cannot capture the complexity of prostate tissues. A four-compartment restriction spectrum imaging (RSI4) model was recently found to optimally characterize pelvic diffusion signals, and the model coefficient for the slowest diffusion compartment, RSI4-C1, yielded greatest tumor conspicuity. In this study, RSI4-C1 was evaluated as a quantitative voxel-level classifier of PCa. Methods: This was a retros...
1 CitationsSource
1 CitationsSource
#1Antonio C. Westphalen (UCSF: University of California, San Francisco)H-Index: 31
#2Charles E. McCulloch (UCSF: University of California, San Francisco)H-Index: 103
Last. Andrew B. Rosenkrantz (NYU: New York University)H-Index: 61
view all 48 authors...
Background Prostate MRI is used widely in clinical care for guiding tissue sampling, active surveillance, and staging. The Prostate Imaging Reporting and Data System (PI-RADS) helps provide a standardized probabilistic approach for identifying clinically significant prostate cancer. Despite widespread use, the variability in performance of prostate MRI across practices remains unknown. Purpose To estimate the positive predictive value (PPV) of PI-RADS for the detection of high-grade prostate can...
63 CitationsSource
Abstract Background The use of 12-core systematic prostate biopsy is associated with diagnostic inaccuracy that contributes to both overdiagnosis and underdiagnosis of prostate cancer. Biopsies per...
161 CitationsSource
#1Baris TurkbeyH-Index: 76
#2Andrew B. Rosenkrantz (NYU: New York University)H-Index: 61
Last. Jeffrey C. Weinreb (Yale University)H-Index: 73
view all 14 authors...
Abstract The Prostate Imaging Reporting and Data System version 2 (PI-RADS v2) was developed with a consensus-based process using a combination of published data, and expert observations and opinions. In the short time since its release, numerous studies have validated the value of PI-RADS v2 but, as expected, have also identified a number of ambiguities and limitations, some of which have been documented in the literature with potential solutions offered. To address these issues, the PI-RADS St...
433 CitationsSource
Cited By0
Newest